Home
Conditions
Neoplasms

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,968 public trials 1,514 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI)

NCT01136005

Conditions: Cancer, Exanthema, Neoplasms, +3 more
Locations: Medisch Centrum Alkmaar Alkmaar, Netherlands

Deventer ziekenhuis Deventer, Netherlands

Admiraal de Ruyter Hospital Goes, Netherlands

Leiden University Medical Centre Leiden, Netherlands

View Trial Details

Completed

Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma

NCT00687622

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: GSK Investigational Site Scottsdale, Arizona, United States

GSK Investigational Site Aurora, Colorado, United States

GSK Investigational Site Fort Myers, Florida, United States

GSK Investigational Site Ocoee, Florida, United States

View Trial Details

Completed

A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of of GSK2118436 in Japanese Subjects With BRAF Mutation Positive Solid Tumors

NCT01582997

Conditions: Cancer, Neoplasms
Locations: GSK Investigational Site Shizuoka, Japan

GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212

NCT01387204

Conditions: Cancer, Neoplasms
Locations: GSK Investigational Site Tacoma, Washington, United States

View Trial Details

Completed

An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma

NCT00992121

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom

View Trial Details

Completed

Carbon-11 Labeled Sarcosine in Prostate Cancer

NCT02462447

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: University of Michigan Health Systems Ann Arbor, Michigan, United States

View Trial Details

Completed

An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer

NCT01266954

Conditions: Neoplasms, Solid Tumours
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

NCT00955773

Conditions: Cancer, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations: GSK Investigational Site Nashville, Tennessee, United States

GSK Investigational Site San Antonio, Texas, United States

GSK Investigational Site Paris, France

View Trial Details

Completed

Impact of Elimination or Reduction of Dietary Animal Proteins on Cancer Progression and Survival - A Pilot Study

NCT02437474

Conditions: Neoplasms
Locations: Verein Essen und Krebs Vienna, Austria

View Trial Details

Completed

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

NCT00964821

Conditions: Anemia, Anemia, Aplastic, Blast Crisis, +73 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Neoplasms

Neoplasms trial results

Related conditions